Expanding antiplatelet use for patients with stroke: the case for stroke of unknown type

Affiliations

• ¹ From the Department of Medicine (A.G.T.), Southern Clinical School, Monash Medical Centre, Monash University; Florey Institute of Neuroscience and Mental Health (A.G.T.), Melbourne, Australia; Stroke & Cerebrovascular Diseases (F.d.l.R.), SANNA-Healthcare Network, Lima, Peru; and the Department of Neurology and Rehabilitation Medicine (F.d.l.R.), University of Cincinnati, OH. amanda.thrift@monash.edu.
• ² From the Department of Medicine (A.G.T.), Southern Clinical School, Monash Medical Centre, Monash University; Florey Institute of Neuroscience and Mental Health (A.G.T.), Melbourne, Australia; Stroke & Cerebrovascular Diseases (F.d.l.R.), SANNA-Healthcare Network, Lima, Peru; and the Department of Neurology and Rehabilitation Medicine (F.d.l.R.), University of Cincinnati, OH.